Skip to main content

ADVERTISEMENT

Michael J. DeSarno, MS

Original Contribution
08/01/2021
RAS inhibition after TAVR has been associated with lower cardiac mortality and heart failure readmissions. We analyzed 735 consecutive TAVR patients (2014-2019) who survived to hospital discharge at a high-volume TAVR center to determine the...
RAS inhibition after TAVR has been associated with lower cardiac mortality and heart failure readmissions. We analyzed 735 consecutive TAVR patients (2014-2019) who survived to hospital discharge at a high-volume TAVR center to determine the...
RAS inhibition after TAVR has...
08/01/2021
Journal of Invasive Cardiology